More than 90% of China's co-ordinating regions have realized real-time settlement of their expenditures. This reporter learned from the State Council's Health Reform Office on the 12th.
According to reports, the most commonly-reported problems in the basic medical insurance services are that the reimbursement of medical expenses requires running errands and funds. Second, it is difficult for the floating population to make medical settlements in different places, and it is difficult to transfer the medical insurance relationship. In addition, how to use medical insurance to guide the medical service supply and demand sides and control the growth of medical expenses, how to strengthen supervision to ensure the safety of medical insurance funds, is also a key concern of the competent department of medical insurance. In order to solve the above problems, it is necessary to improve medical insurance management service capabilities.
Through unremitting efforts, China's basic medical security management service capabilities have been continuously strengthened. At present, more than 90% of the co-ordinating areas have achieved real-time settlement and settlement of expenditures, and Fujian, Jiangsu, Henan, Hubei, Hunan, and other provinces have carried out medical and networking settlements in different places within the province.
Shanghai, Henan, Jiangsu, Ningxia and other places explore the implementation of a total price advance, disease-by-disease, per capita payment methods, Jilin Changchun, Heilongjiang Keshan, Sichuan Chengdu and other places to explore the "price negotiation mechanism" of medical insurance, medical costs have been initially controlled, medicine The proportion of the patients and the average length of stay decreased, the use of antibiotics and hormones decreased, the actual compensation ratio increased, and the patient's medical expenses decreased.
More than 40 cities including Tianjin, Chongqing, and Ningxia, as well as Chengdu, Hangzhou, and Xiamen, have achieved urban-rural integration of the basic medical insurance system.
According to reports, the most commonly-reported problems in the basic medical insurance services are that the reimbursement of medical expenses requires running errands and funds. Second, it is difficult for the floating population to make medical settlements in different places, and it is difficult to transfer the medical insurance relationship. In addition, how to use medical insurance to guide the medical service supply and demand sides and control the growth of medical expenses, how to strengthen supervision to ensure the safety of medical insurance funds, is also a key concern of the competent department of medical insurance. In order to solve the above problems, it is necessary to improve medical insurance management service capabilities.
Through unremitting efforts, China's basic medical security management service capabilities have been continuously strengthened. At present, more than 90% of the co-ordinating areas have achieved real-time settlement and settlement of expenditures, and Fujian, Jiangsu, Henan, Hubei, Hunan, and other provinces have carried out medical and networking settlements in different places within the province.
Shanghai, Henan, Jiangsu, Ningxia and other places explore the implementation of a total price advance, disease-by-disease, per capita payment methods, Jilin Changchun, Heilongjiang Keshan, Sichuan Chengdu and other places to explore the "price negotiation mechanism" of medical insurance, medical costs have been initially controlled, medicine The proportion of the patients and the average length of stay decreased, the use of antibiotics and hormones decreased, the actual compensation ratio increased, and the patient's medical expenses decreased.
More than 40 cities including Tianjin, Chongqing, and Ningxia, as well as Chengdu, Hangzhou, and Xiamen, have achieved urban-rural integration of the basic medical insurance system.
Bifidobacterium Infantis,Bifidobacterium Infantis Probiotic,Bifidobacterium Infantis Products,Bifidobacterium Infantis Supplement
Jiangsu Biodep Biotechnology Co. ,Ltd. , https://www.mbioda.com